🔗 Share this article

The top legal official in Texas Ken Paxton is taking legal action against the manufacturers of Tylenol, asserting the firms hid potential risks that the pain reliever presented to pediatric neurological development.

The court filing comes a month after Former President Trump publicized an unsubstantiated connection between using Tylenol - also known as acetaminophen - while pregnant and autism in offspring.

The attorney general is suing the pharmaceutical giant, which previously sold the medication, the only pain reliever suggested for women during pregnancy, and the current manufacturer, which presently makes it.

In a declaration, he claimed they "betrayed America by profiting off of pain and marketing drugs regardless of the potential hazards."

The company states there is insufficient reliable data tying acetaminophen to autism spectrum disorder.

"These companies deceived for years, knowingly endangering millions to boost earnings," the attorney general, from the Republican party, said.

The company stated officially that it was "seriously troubled by the perpetuation of misinformation on the security of paracetamol and the possible consequences that could have on the well-being of US mothers and children."

On its official site, Kenvue also said it had "consistently assessed the relevant science and there is no credible data that demonstrates a verified association between consuming paracetamol and autism."

Organizations acting on behalf of medical professionals and medical practitioners share this view.

The leading OB-GYN organization has stated acetaminophen - the key substance in acetaminophen - is a restricted selection for expectant mothers to manage discomfort and fever, which can create serious health risks if left untreated.

"In more than two decades of studies on the utilization of paracetamol in gestation, no reliable research has definitively established that the usage of paracetamol in any stage of gestation causes neurological conditions in young ones," the organization commented.

This legal action cites recent announcements from the former administration in arguing the medication is potentially dangerous.

In recent weeks, the former president generated worry from health experts when he told expectant mothers to "resist strongly" not to use Tylenol when ill.

Federal regulators then published an announcement that doctors should contemplate reducing the consumption of Tylenol, while also stating that "a direct connection" between the medication and autism spectrum disorder in children has not been established.

The Health Department head Kennedy, who supervises the Food and Drug Administration, had vowed in April to initiate "a massive testing and research effort" that would determine the origin of autism spectrum disorder in a matter of months.

But authorities warned that discovering a single cause of autism spectrum disorder - considered by experts to be the result of a complicated interplay of inherited and external influences - would not be simple.

Autism spectrum disorder is a form of lifelong neurodivergence and condition that impacts how persons encounter and engage with the environment, and is recognized using doctors' observations.

In his court filing, Paxton - who supports Trump who is seeking federal office - alleges the manufacturer and J&J "willfully ignored and sought to suppress the science" around paracetamol and autism spectrum disorder.

The lawsuit attempts to require the firms "remove any commercial messaging" that claims Tylenol is secure for pregnant women.

The Texas lawsuit parallels the grievances of a assembly of guardians of young ones with autism spectrum disorder and attention deficit hyperactivity disorder who took legal action against the producers of acetaminophen in two years ago.

The court threw out the legal action, saying research from the plaintiffs' authorities was inconclusive.